14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Aug 29, 2022 $0.430 $0.454 $0.415 $0.428 870 315
Aug 26, 2022 $0.431 $0.440 $0.420 $0.425 398 262
Aug 25, 2022 $0.425 $0.434 $0.416 $0.432 462 939
Aug 24, 2022 $0.414 $0.415 $0.402 $0.415 484 746
Aug 23, 2022 $0.410 $0.414 $0.390 $0.410 486 353
Aug 22, 2022 $0.400 $0.405 $0.390 $0.402 684 200
Aug 19, 2022 $0.429 $0.434 $0.380 $0.395 1 530 854
Aug 18, 2022 $0.453 $0.453 $0.400 $0.424 1 394 034
Aug 17, 2022 $0.470 $0.470 $0.431 $0.440 1 385 206
Aug 16, 2022 $0.485 $0.490 $0.451 $0.478 1 722 505
Aug 15, 2022 $0.447 $0.487 $0.445 $0.480 2 652 174
Aug 12, 2022 $0.427 $0.460 $0.422 $0.442 1 926 583
Aug 11, 2022 $0.430 $0.435 $0.417 $0.428 1 096 481
Aug 10, 2022 $0.413 $0.435 $0.405 $0.425 1 250 506
Aug 09, 2022 $0.411 $0.420 $0.401 $0.411 1 177 062
Aug 08, 2022 $0.398 $0.420 $0.390 $0.414 2 514 352
Aug 05, 2022 $0.390 $0.411 $0.382 $0.384 1 430 902
Aug 04, 2022 $0.390 $0.409 $0.382 $0.392 1 961 667
Aug 03, 2022 $0.375 $0.391 $0.375 $0.387 2 630 623
Aug 02, 2022 $0.375 $0.376 $0.370 $0.373 778 221
Aug 01, 2022 $0.375 $0.380 $0.365 $0.369 657 536
Jul 29, 2022 $0.373 $0.375 $0.360 $0.374 807 513
Jul 28, 2022 $0.374 $0.375 $0.360 $0.369 1 209 272
Jul 27, 2022 $0.376 $0.385 $0.361 $0.379 1 298 284
Jul 26, 2022 $0.361 $0.382 $0.361 $0.379 1 722 252
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT